APA aipamena

Foulkes, W. D., Stamp, G. W., Afzal, S., Lalani, N., McFarlane, C. P., Trowsdale, J., & Campbell, I. G. (1995). MDM2 overexpression is rare in ovarian carcinoma irrespective of TP53 mutation status. Nature Publishing Group.

Chicago Style aipamena

Foulkes, W. D., G. W. Stamp, S. Afzal, N. Lalani, C. P. McFarlane, J. Trowsdale, and I. G. Campbell. MDM2 Overexpression Is Rare in Ovarian Carcinoma Irrespective of TP53 Mutation Status. Nature Publishing Group, 1995.

MLA aipamena

Foulkes, W. D., et al. MDM2 Overexpression Is Rare in Ovarian Carcinoma Irrespective of TP53 Mutation Status. Nature Publishing Group, 1995.